Treatment of Atrial Fibrillation
- 21 July 2015
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 314 (3), 278-288
- https://doi.org/10.1001/jama.2015.7505
Abstract
Importance Atrial fibrillation is a common arrhythmia that affects more than 2.5 million people in the United States and causes substantial morbidity and mortality, especially regarding the increased risk of stroke. Objective To summarize atrial fibrillation treatment exclusive of stroke prevention. Evidence Review An Ovid MEDLINE comprehensive literature search was performed on atrial fibrillation therapy excluding anticoagulation and emphasizing studies published within the last 5 years through April 2015 (N = 5044 references). The 2014 atrial fibrillation guideline from the American Heart Association, the American College of Cardiology, and the Heart Rhythm Society also was reviewed. Findings Reversible causes of atrial fibrillation should be identified. Risk factor modification, including weight loss and treatment of hypertension, diabetes, and obstructive sleep apnea can reduce atrial fibrillation episodes. Appropriate anticoagulation is necessary for patients at substantial stroke risk regardless of rate or rhythm treatment strategy. Sinus rhythm is often needed to control symptoms; however, an alternative strategy for atrial fibrillation is appropriate rate control. Rate control is safe in older patients (those who are about age ≥65 years) followed up for a few years, but no such safety data exist for patients younger than 60 years or for those followed up for longer periods. Thus, selection of therapy is individualized, taking into account present and future medical problems for the patient. Choice of an antiarrhythmic drug is based on safety first vs efficacy. Catheter ablation is an effective nonpharmacological alternative that is often, but not always, the second-line treatment. Reduction of the frequency and duration of atrial fibrillation episodes that result in a significant improvement in quality of life is a good marker of drug treatment success and complete elimination of atrial fibrillation is not required in many patients. Rate control is usually achieved with a β-blocker or non–dihydropyridine calcium channel blockers. It is important to assess adequate rate control during both rest and activity. If the ventricular rate goes uncontrolled for a prolonged period, tachycardia-mediated cardiomyopathy can occur. Conclusions and Relevance Therapy for atrial fibrillation includes prevention and modification of inciting causes and appropriate anticoagulation. Rate control is necessary for all patients. Maintenance of sinus rhythm with drugs or catheter ablation should be considered based on the individual needs of each patient.Keywords
This publication has 67 references indexed in Scilit:
- Long‐term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta‐analysisJournal of the American Heart Association, 2013
- Treatment of Atrial Fibrillation by the Ablation of Localized Sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) TrialJournal of the American College of Cardiology, 2012
- Clinical Mapping Approach To Diagnose Electrical Rotors and Focal Impulse Sources for Human Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2012
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Implementing GRADE and Achieving ConsensusCanadian Journal of Cardiology, 2011
- Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm ManagementCanadian Journal of Cardiology, 2011
- Reversal of Left Ventricular Dysfunction Following Ablation of Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2006
- Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1992
- Tachycardia-induced cardiomyopathy: A reversible form of left ventricular dysfunctionThe American Journal of Cardiology, 1986
- A computer model of atrial fibrillationAmerican Heart Journal, 1964
- Experimental studies on auricular flutter and auricular fibrillationAmerican Heart Journal, 1948